Quillivant XR 25 MG/5 ML susp 120ML
Ended Awarded
- Contract number
- SPE2DB25FYCRT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,963
Award facts
- Contract value 100% obligated
- $2,962.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL), a medication used to treat attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $2,962.82, represents a non-competitive set-aside award and is scheduled for completion by September 23, 2025. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's federal contracting history demonstrates consistent competitively awarded delivery orders with firm fixed pricing across multiple therapeutic domains, supporting military healthcare programs worldwide. The DLA Troop Support Medical contract provides the foundational vehicle enabling AmerisourceBergen to fulfill ongoing pharmaceutical procurement needs for federal defense and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FYCRT?
SPE2DB25FYCRT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FYCRT worth?
The government has obligated $2,963 on SPE2DB25FYCRT.
Is contract SPE2DB25FYCRT an order under another contract?
Yes. SPE2DB25FYCRT is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FYCRT competed?
The extent of competition for SPE2DB25FYCRT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award